Picture of Cyxone AB logo

CYXO Cyxone AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Cyxone AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
SAS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-35.2-49-45-42.5-23
Depreciation
Amortisation
Non-Cash Items2.01
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.852.32-0.017-1.1-0.211
Change in Accounts Receivable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-35.2-44.9-43.3-41.3-19.4
Capital Expenditures-0.036-0.159-0.892-8.16-6.82
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.955-0.0190-0.3220
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.991-0.178-0.892-8.48-6.82
Financing Cash Flow Items-3.16-1.31-1.1-11.3-5.01
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities59.339.717.149.514.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash23-5.41-27-0.11-11.7